Amydis, Inc.
PrivateLast Round
Grant
Mar 11, 2026
Total Funding Raised
$21.53M
Company Overview
Amydis, Inc. is a biotechnology company developing proprietary ocular tracers that enable the identification of molecular biomarkers for diseases of the eye, heart, and brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Imaging, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amydis, Inc. Comps
Public and private peers based on sector, stage, and business model.
Amydis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 11, 2026 | ||||
| Grant | Nov 14, 2023 | ||||
| Series A Extension | Dec 29, 2022 | ||||
| Grant | Oct 27, 2022 | ||||
| Series A | Apr 22, 2022 | ||||
Grant | Sep 2, 2021 |
Key People
Founding team and executive leadership
Amydis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Series A Extension |
| NIH RADx | Grant, Series A Extension |
| National Institute on Aging | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Series A Extension |
| National Institute of Neurological Disorders and Stroke | Series A Extension |
| National Institutes of Health (NIH) | Grant |
| Stead Impact Ventures and Foundation | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
$3M grant round led by National Institute on Aging.
- Nov 8, 2025
Monthly visitors increased 138% MoM, reaching 3.4K.
Amydis, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amydis, Inc.'s valuation, stock price, and market status.
